الفهرس Only 14 pages are availabe for public view
 |  | from | 112 |  |  |
| | | from | 112 | | |
Abstract
Oral anticoagulant therapy is used commonly in elderly AF patients requiring cataract surgery. A decision has to be made whether to continue anticoagulants therapy or not. On one hand, continuing such treatments is frequently thought to increase both the risk for surgical bleeding and the risk of haematoma from eye block puncture. On the other hand, discontinuing those therapies may unacceptably increase the risk for thrombosis in at-risk patients, for example, those with atrial fibrillation, non-tissue prosthetic heart valves, carotid stenosis or coronary drug-eluting stents. These risks include cerebral ischemic stroke, myocardial infarction and death. In fact, cataract surgery is considered a {u2018}bloodless{u2019} procedure. from all the studies quoted we can say that warfarin can be continued safely in AF patients undergoing cataract surgery